- ALBO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Albireo Pharma (ALBO) 8-K11 Oct 22Albireo Reports Positive Topline Data from Phase 3 Trial of Bylvay® (odevixibat) in Alagille SyndromeFinancial data
Company Profile